Gefitinib Faran

Gefitinib Faran is an oral medication used to treat certain types of cancer. This pharmaceutical is manufactured by Faran S.A. and is intended for oral use.

Gefitinib Faran is primarily used in the treatment of specific types of cancer. It is often prescribed for patients with non-small cell lung cancer that has certain genetic features. The medication works by targeting and inhibiting the growth of cancer cells. Patients should consult their healthcare provider to determine if Gefitinib Faran is suitable for their condition.

Common effects of Gefitinib Faran may include skin rash, diarrhea, and appetite loss. Some users may also experience dry skin, nausea, or vomiting. These effects can vary in intensity and duration. It is important to monitor any adverse reactions and consult a healthcare professional if they become severe or persistent.

Gefitinib Faran should be handled with care and stored as directed. It is essential to follow the prescribed dosage and administration instructions provided by a healthcare professional. Patients with certain medical conditions or allergies should inform their doctor before starting this medication. Pregnant or breastfeeding women should also consult their healthcare provider.

Gefitinib Faran may interact with other medications, including those that are metabolized by the liver. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain foods may also affect the efficacy of Gefitinib Faran. Always consult a healthcare professional for personalized advice.